MeganAnnMezeraMD

Director of Brachytherapy, Clinical Director of MR Linac, MD Anderson Cancer Center at Cooper University Health Care, Associate Professor CMSRU

Dr. Mezera is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
Two Cooper Plaza 400 Haddon Ave
Camden, NJ 08103
Phone+1 855-632-2667

Fax+1 856-735-6467

Dr. Megan Mezera is a radiation oncologist based in Camden, NJ, with extensive training from Chicago Medical School and the University of Louisville School of Medicine. After completing her internship in internal medicine at Boston University Medical Center, she pursued residency and chief residency in radiation oncology at the University of Louisville. She has held assistant professor and associate professor roles at Cooper University Health Care and UofL Hospital. Dr. Mezera has contributed to research with publications in respected journals, notably on topics such as 3D-printed oral stents and SARS-CoV-2 testing in radiation therapy patients.

University of Louisville School of MedicineChief Residency, Radiation Oncology, 2014 - 2015
University of Louisville School of MedicineResidency, Radiation Oncology, 2011 - 2015
Boston University Medical CenterInternship, Internal Medicine, 2010 - 2011
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 2010

PubMed

Journal Articles

Evaluating patterns of failure and salvage therapy for patients treated with primary stereotactic body radiation therapy for early stage non-small cell lung cancer.
Mezera MA, Chandrasekhar M, Kloecker G, Van Berkel V, Bousamra M, Dunlap NE, Journal of Solid Tumors, 11/2014
Evaluating patterns of failure and salvage therapy for patients treated with primary stereotactic body radiation therapy for early stage non-small cell lung cancer.
Mezera MA, Chandrasekhar M, Kloecker G, Van Berkel V, Bousamra M, Dunlap NE, Journal of Solid Tumors, 5/2014